- Home
- GSK vs CRWD Comparison
GSK vs CRWD Comparison
Compare GSK & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSK | CRWD |
|---|---|---|
| Founded | 1715 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.9B | 118.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GSK | CRWD |
|---|---|---|
| Price | $50.64 | $459.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 43 |
| Target Price | N/A | ★ $549.63 |
| AVG Volume (30 Days) | ★ 3.1M | 2.1M |
| Earning Date | 02-04-2026 | 12-02-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 118.57 | N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $43,237,357,842.00 | $4,565,168,000.00 |
| Revenue This Year | $6.70 | $23.94 |
| Revenue Next Year | $5.10 | $22.04 |
| P/E Ratio | $27.45 | ★ N/A |
| Revenue Growth | 2.73 | ★ 22.05 |
| 52 Week Low | $31.72 | $298.00 |
| 52 Week High | $49.63 | $566.90 |
Technical Indicators
Market Signals| Indicator | GSK | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 67.52 | 33.74 |
| Support Level | $48.59 | $449.46 |
| Resistance Level | $49.40 | $483.29 |
| Average True Range (ATR) | 0.56 | 10.85 |
| MACD | 0.04 | -2.16 |
| Stochastic Oscillator | 75.11 | 23.52 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.